BTK inhibitors could be beneficial in treating multiple forms of urticarial eruptions, including AU, because of their effect on FcεRI-mediated mast cell activation, as well as B-cell functionality and the basophil signal cascade [18]. The gene discussed is BTK; the disease is alopecia universalis congenita.